Breaking: CVS Health Q4 earnings arrive above consensus, but guidance sends shares lower

CVS Health reported positive Q4 earnings before the market opened on Wednesday, February 9. Adjusted earnings per share (EPS) of $1.98 beat Wall Street consensus by 5%, and revenue of $76.6 billion beat forecasts by 1.5%.
The retailer confirmed adjusted EPS for the full year ahead of between $8.10 and $8.30 but lowered its guidance on cash flow from operations to between $12 and $13 billion rather than from $12.5 to $13 billion. CVS shares are down 2.6% to $107.93 in Wednesday's premarket.
Premium
You have reached your limit of 3 free articles for this month.
Start your subscription and get access to all our original articles.
Author

Clay Webster
FXStreet
Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

















